Specific immunofluorimetric assay detecting the chemotactic epitope of the urokinase receptor (uPAR)

Journal of Immunological Methods

Volumn 308, Issue 1-2, 2006, Pages 192-202

  Resnati, Massimo ^a   Pallavicini, Isabella ^a   Daverio, Rita ^b   Sidenius, Nicolai ^a   Bonini, Pierangelo ^b   Blasi, Francesco ^a  

^a VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

^b SAN RAFFAELE HOSPITAL   (Italy)

Author keywords

Cancer; Chemotaxis; ELISA; Monoclonal antibodies; Urokinase receptor

Indexed keywords

EPITOPE; MONOCLONAL ANTIBODY; POLYCLONAL ANTIBODY; SYNTHETIC PEPTIDE; UROKINASE RECEPTOR;

AMINO TERMINAL SEQUENCE; ARTICLE; BLOOD ANALYSIS; CHEMOTAXIS; COLORECTAL CARCINOMA; CONTROLLED STUDY; CROSS REACTION; ENZYME IMMUNOASSAY; FLUOROMETRY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROSTATE CARCINOMA; SENSITIVITY AND SPECIFICITY; URINALYSIS;

AMINO ACID SEQUENCE; ANIMALS; ANTIBODIES, MONOCLONAL; BLOTTING, WESTERN; CELL LINE; CERCOPITHECUS AETHIOPS; CHEMOTACTIC FACTORS; CHO CELLS; COS CELLS; CRICETINAE; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPITOPES; FLOW CYTOMETRY; FLUOROIMMUNOASSAY; HUMANS; IMMUNOPRECIPITATION; MICE; PEPTIDE FRAGMENTS; RABBITS; RECEPTORS, CELL SURFACE; RECOMBINANT PROTEINS; SENSITIVITY AND SPECIFICITY;

ORYCTOLAGUS CUNICULUS;

EID: 30844459649     PISSN: 00221759     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jim.2005.10.013     Document Type: Article

References (34)

1. A. Andolfo, W.R. English, M. Resnati, G. Murphy, F. Blasi, and N. Sidenius Metalloproteases cleave the urokinase-type plasminogen activator receptor in the D1-D2 linker region and expose epitopes not present in the intact soluble receptor Thromb. Haemost. 88 2002 298
2. N. Beaufort, D. Leduc, J.C. Rousselle, V. Magdolen, T. Luther, A. Namane, M. Chignard, and D. Pidard Proteolytic regulation of the urokinase receptor/CD87 on monocytic cells by neutrophil elastase and cathepsin G J. Immunol. 172 2004 540
3. N. Behrendt, M. Ploug, L. Patthy, G. Houen, F. Blasi, and K. Dano The ligand-binding domain of the cell surface receptor for urokinase-type plasminogen activator J. Biol. Chem. 266 1991 7842
4. F. Blasi, and P. Carmeliet uPAR: a versatile signaling orchestrator Nat. Rev., Mol. Cell Biol. 3 2002 932
5. O. Cunningham, A.P. Andolfo, M.L. Santovito, L. Iuzzolino, F. Blasi, and N. Sidenius Dimerization controls the lipid raft partitioning of uPAR/CD87 and regulates its biological functions EMBO J. 22 2003 5994
6. B. Degryse, M. Resnati, S.A. Rabbani, A. Villa, F. Fazioli, and F. Blasi Src-dependence and pertussis-toxin sensitivity of urokinase receptor-dependent chemotaxis, and cytoskeleton reorganization in rat smooth muscle cells via the urokinase receptor Blood 94 1999 649
7. F. Fazioli, M. Resnati, N. Sidenius, Y. Higashimoto, E. Appella, and F. Blasi A urokinase-sensitive region of the human urokinase receptor is responsible for its chemotactic activity EMBO J. 16 1997 7279
8. F. Furlan, S. Orlando, C. Laudanna, M. Resnati, V. Basso, F. Blasi, and A. Mondino The soluble D2D3 (88-274) fragment of the urokinase receptor inhibits monocyte chemotaxis and integrin-dependent cell adhesion J. Cell. Sci. 117 2004 2909
9. G. Hoyer-Hansen, E. Ronne, H. Solberg, N. Behrendt, M. Ploug, L.R. Lund, V. Ellis, and K. Dano Urokinase plasminogen activator cleaves its cell surface receptor releasing the ligand-binding domain J. Biol. Chem. 267 1992 18224
10. G. Hoyer-Hansen, M. Ploug, N. Behrendt, E. Ronne, and K. Dano Cell surface acceleration of urokinase-catalyzed receptor cleavage Eur. J. Biochem. 243 1997 21
11. G. Hoyer-Hansen, U. Pessara, A. Holm, J. Pass, U. Weidle, K. Dano, and N. Behrendt Urokinase-catalyzed cleavage of the urokinase receptor requires an intact glycolipid anchor Biochem. J. 358 2001 673
12. P. Koolwijk, N. Sidenius, E. Peters, C.F. Sier, R. Hanemaaijer, F. Blasi, and V.W. van Hinsbergh Proteolysis of the urokinase-type plasminogen activator receptor by metalloproteinase-12: implication for angiogenesis in fibrin matrices Blood 97 2001 3123
13. P. Llinas, M.H. Le Du, H. Gardsvoll, K. Dano, M. Ploug, B. Gilquin, and E.A.M. Stura Crystal structure of the human urokinase plasminogen activator receptor bound to an antagonist peptide EMBO J. 24 2005 1655
14. M.T. Masucci, N. Pedersen, and F. Blasi A soluble, ligand binding mutant of the human urokinase plasminogen activator receptor J. Biol. Chem. 266 1991 8655
15. I.F. Mizukami, N.E. Faulkner, M.R. Gyetko, R.G. Sitrin, and R.F. Todd III Enzyme-linked immunoabsorbent assay detection of a soluble form of urokinase plasminogen activator receptor in vivo Blood 86 1995 203
16. S. Mustjoki, N. Sidenius, C.F. Sier, F. Blasi, E. Elonen, R. Alitalo, and A. Vaheri Soluble urokinase receptor levels correlate with number of circulating tumor cells in acute myeloid leukemia and decrease rapidly during chemotherapy Cancer Res. 60 2000 7126
17. D.H. Nguyen, D.J. Webb, A.D. Catling, Q. Song, A. Dhakephalkar, M.J. Weber, K.S. Ravichandran, and S.L. Gonias Urokinase-type plasminogen activator stimulates the Ras/extracellular signal-regulated kinase (ERK) signaling pathway and MCF-7 cell migration by a mechanism that requires focal adhesion kinase, Src, and Shc. Rapid dissociation of GRB2/Sps-Shc complex is associated with the transient phosphorylation of ERK in urokinase-treated cells J. Biol. Chem. 275 2000 19382
18. L. Ossowski, and J.A. Aguirre Ghiso Urokinase receptor and integrin partnership: coordination of signaling for cell adhesion, migration and growth Curr. Opin. Cell Biol. 12 2000 613
19. N. Pedersen, M. Schmitt, E. Rønne, M.I. Nicoletti, G. Høyer-Hansen, M. Conese, R. Gavazzi, K. Dano, W. Kuhn, and F. Janicke A ligand-free, soluble urokinase receptor is present in the ascitic fluid from patients with ovarian cancer J. Clin. Invest. 92 1993 2160
20. M. Ploug Structure-function relationships in the interaction between the urokinase-type plasminogen activator and its receptor Curr. Pharm. Des. 9 2003 1499
21. M. Ploug, E. Ronne, N. Behrendt, A.L. Jensen, F. Blasi, and K. Dano Cellular receptor for urokinase plasminogen activator. Carboxyl-terminal processing and membrane anchoring by glycosyl-phosphatidylinositol J. Biol. Chem. 266 1991 1926
22. M. Resnati, M. Guttinger, S. Valcamonica, N. Sidenius, F. Blasi, and F. Fazioli Proteolytic cleavage of the urokinase receptor substitutes for the agonist-induced chemotactic effect EMBO J. 15 1996 1572
23. M. Resnati, I. Pallavicini, J.M. Wang, J. Oppenheim, C.N. Serhan, M. Romano, and F. Blasi The fibrinolytic receptor for urokinase activates the G protein-coupled chemotactic receptor FPRL1/LXA4R Proc. Natl. Acad. Sci. U. S. A. 99 2002 1359
24. A.L. Roldan, M.V. Cubellis, M.T. Masucci, N. Behrendt, L.R. Lund, K. Dano, E. Appella, and F. Blasi Cloning and expression of the receptor for human urokinase plasminogen activator, a central molecule in cell-surface, plasmin dependent proteolysis EMBO J. 9 1990 467
25. E. Ronne, N. Behrendt, M. Ploug, H.J. Nielsen, E. Wollisch, U. Weidle, K. Dano, and G. Hoyer-Hansen Quantitation of the receptor for urokinase plasminogen activator by enzyme-linked immunosorbent assay J. Immunol. Methods 167 1994 91
26. N. Sidenius, C.F. Sier, H. Ullum, B.K. Pedersen, A.C. Lepri, F. Blasi, and J. Eugen-Olsen Serum level of soluble urokinase-type plasminogen activator receptor is a strong and independent predictor of survival in human immunodeficiency virus infection Blood 96 2000 4091
27. N. Sidenius, CF. Sier, and F. Blasi Shedding and cleavage of the urokinase receptor (uPAR): identification and characterisation of uPAR fragments in vitro and in vivo FEBS Lett. 475 2000 52
28. C.F. Sier, R. Stephens, J. Bizik, A. Mariani, M. Bassan, N. Pedersen, L. Frigerio, A. Ferrari, K. Dano, N. Brunner, and F. Blasi The level of urokinase-type plasminogen activator receptor is increased in serum of ovarian cancer patients Cancer Res. 58 1998 1843
29. C.F. Sier, I. Nicoletti, M.L. Santovito, T. Frandsen, G. Aletti, A. Ferrari, A. Lissoni, R. Gavazzi, F. Blasi, and N. Sidenius Metabolism of tumour-derived urokinase receptor and receptor fragments in cancer patients and xenografted mice Thromb. Haemost. 91 2004 403
30. R.W. Stephens, H.J. Nielsen, I.J. Christensen, O. Thorlacius-Ussing, S. Sorensen, K. Dano, and N. Brunner Plasma urokinase receptor levels in patients with colorectal cancer: relationship to prognosis J. Natl. Cancer Inst. 91 1999 869
31. M.P. Stoppelli, A. Corti, A. Soffientini, G. Cassani, F. Blasi, and R.K. Assoian Differentiation-enhanced binding of the amino-terminal fragment of human urokinase plasminogen activator to a specific receptor on U937 monocytes Proc. Natl. Acad. Sci. U. S. A. 82 1985 4939
32. J.D. Vassalli, D. Baccino, and D. Belin A cellular binding site for the Mr 55,000 form of the human plasminogen activator urokinase J. Cell Biol. 100 1985 86
33. K. Wahlberg, G. Hoyer-Hansen, and B. Casslen Soluble receptor for urokinase plasminogen activator in both full-length and a cleaved form is present in high concentration in cystic fluid from ovarian cancer Cancer Res. 58 1998 3294
34. Y. Wei, M. Lukashev, D.I. Simon, S.C. Bodary, S. Rosenberg, M.V. Doyle, and H.A. Chapman Regulation of integrin function by the urokinase receptor Science 273 1996 1551